Press Releases

GlobeNewswire, Inc.

NEW YORK, May 13, 2026 (GLOBE NEWSWIRE) -- Berry Street, the leading metabolic health company transforming nutrition therapy, and Factor, America’s leading ready-to-heat meal delivery service, today announced a new partnership to provide...

EIN Presswire

ALPHARETTA, GA, UNITED STATES, May 13, 2026 /⁨EINPresswire.com⁩/ -- MagVenture, a global leader in non-invasive neuromodulation technology, today announced the launch of the MagVenture Go™ Portable TMS system, a compact and mobile transcranial...

GlobeNewswire, Inc.

CAMBRIDGE, Mass., May 11, 2026 (GLOBE NEWSWIRE) -- Orphan Therapeutics Accelerator (OTXL), a non-profit biotech focused on completing development and enabling commercial access to stalled rare disease treatments, today announced that AGC...

EIN Presswire

A 98% employee approval rating and 2026 Great Place to Work® win confirms VELA Chairs’ status as a global leader in quality and workplace excellence.

GlobeNewswire, Inc.

TARPON SPRINGS, Fla., May 8, 2026 – Allarity Therapeutics, Inc. (“Allarity” or the “Company”) (NASDAQ: ALLR), a Phase 2 clinical-stage pharmaceutical company dedicated to developing stenoparib (2X-121)—a differentiated, dual PARP and WNT pathway...

International Committee of the Red Cross

“The entry of medical equipment and supplies for the Red Cross Field Hospital is a positive step towards responding to the medical needs of people in Gaza,” said Julien Lerisson, the ICRC’s head of delegation in Israel and the Occupied...

International Committee of the Red Cross

Over the last two years, the Red Cross Field Hospital has been a constant in Gaza's fractured health landscape.

GlobeNewswire, Inc.

Company announcement – No. 14 / 2026 Zealand Pharma Announces Financial Results for the First Three Months of 2026 A defining start to 2026, marked by pivotal progress for leading obesity assets, petrelintide and survodutide, and strong momentum...

GlobeNewswire, Inc.

SONATA-HCM anticipated to be fully enrolled mid-2026 Resubmission of NDA for ZYNQUISTA® in type 1 diabetes anticipated mid-2026 with potential for approval this year Clinical development of LX9851 initiated by Novo Nordisk Capital raise,...

GlobeNewswire, Inc.

- Q1 2026 revenue of €197 million for YORVIPATH® and €44 million for SKYTROFA® - More than 1,000 new patient enrollments for YORVIPATH in the U.S. in Q1 - As of May 1, more than 60 YUVIWEL® enrollments since early April U.S. commercial launch -...

GlobeNewswire, Inc.

Company announcement No. 15 / 2026 Zealand Pharma - Execution framework for share buy-back program Copenhagen, Denmark, May 7, 2026 – Zealand Pharma A/S ("the Company" or “Zealand Pharma”) (Nasdaq: ZEAL) (CVR-no. 20045078), a biotechnology company...

GlobeNewswire, Inc.

Company announcement No. 13 / 2026 Zealand Pharma initiates USD 200 million / DKK 1.3 billion share buy-back program Robust cash position of USD 2.3 billion (DKK 14.5 billion) as of March 31, 2026 Financial strength to be further enhanced by...

DVIDS - Georgia

LANDSTUHL, Germany – Landstuhl Regional Medical Center (LRMC) recently welcomed a cohort of military chaplains from Norway and Denmark for its Clinical Pastoral Education (CPE) program, held April 20 to May 7. The three-week program is designed to...

EIN Presswire

Board-certified family medicine physician Dr. Monalisa Ghose supports Shamrock Medicine’s primary care access for adults in Philadelphia and Chestnut Hill. PHILADELPHIA, PA, UNITED STATES, May 6, 2026 /⁨EINPresswire.com⁩/ -- Shamrock Medicine, an...

International Committee of the Red Cross

Thank you, Madam Chair.

GlobeNewswire, Inc.

Press release - No. 9 / 2026 The Zealand Pharma Board of Directors proposes to elect Camilla Sylvest to the Board of Directors at an upcoming Extraordinary General Meeting Camilla Sylvest will bring deep commercial expertise to the Board at a...

GlobeNewswire, Inc.

Company announcement – No. 12 / 2026 Zealand Pharma convenes Extraordinary General Meeting on May 26, 2026 Copenhagen, Denmark, May 1, 2026 – Zealand Pharma A/S ("the Company" or “Zealand Pharma”) (Nasdaq: ZEAL) (CVR-no. 20045078), a biotechnology...

GlobeNewswire, Inc.

New Clinical Data Reinforce Proclarix® Performance in Reducing Overdiagnosis and Unnecessary Biopsies; Multi-Center PRIME Study Initiated in Collaboration with Labcorp; European Commercial Expansion Advances CINCINNATI, Ohio, May 13, 2026 (GLOBE...

GlobeNewswire, Inc.

Press Release – No. 8 / 2026 Zealand Pharma conference call on May 7 at 2pm CET (8am ET) to present first quarter 2026 financial results Copenhagen, Denmark and Boston, Massachusetts, April 30, 2026 – Zealand Pharma A/S (Nasdaq: ZEAL) (CVR-no....

GlobeNewswire, Inc.

Company announcement – No. 11 / 2026 Zealand Pharma and Roche to advance petrelintide, an amylin analog, to Phase 3 trials for chronic weight management Phase 3 trials for chronic weight management planned for initiation in the second half of 2026...